MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease

S. Choudhury, P. Abhilash, P. Alladi (Bengaluru, India)

Meeting: 2024 International Congress

Abstract Number: 1790

Keywords: Aging, Microglia, Parkinson’s

Category: Parkinson's Disease: Pathophysiology

Objective: To delineate the age-associated changes in microglial morphotypes in the substantia nigra pars compacta (SNpc) of C57BL/6J and CD-1 mice and alterations in response to MPTP

Background: Microglia are key players in the pathogenesis of Parkinson’s disease (PD), for which, age is a major risk factor. As neurons age, glia undergo changes in phenotype and functions, resulting in neuroinflammation. We recapitulated the phenomenon of differential susceptibility to PD by comparing the degenerative events in the SNpc of MPTP-resistant CD-1 and MPTP- susceptible C57BL/6J mice. Here we performed detailed examinations of changes in microglial phenotypes, with age and in response to the neurotoxin MPTP

Method: We studied both the strains (n=3-5/strain/experimental condition) at 3 age-periods i.e. 15-17w (young),12 months (middle-aged) and 18 months (old). They received either normal saline or 4 doses of MPTP-HCl (15mg/kg, i.p.) at 2-h intervals. 7 days post-MPTP, mice brains were harvested and 40µ thick midbrain cryosections were sequentially immunostained for TH and Iba-1. Morphotyping was performed on captured images by LAS-X software and “Windows-based” image analysis. Mixed effects model with Tukey’s post-hoc analysis was applied for statistics

Results: The C57BL6J and CD-1 did not show any significant differences in the no. of microglia/field at baseline, at young and middle age; whereas at old age the CD-1 had more microglia.Type-1 microglia were significantly more in MPTP-injected C57BL/6J at young (C57BL/6J vs CD-1;**p<0.01) and middle age (C57BL/6J vs CD-1;*p<0.05), but the differences thinned at old age. The type-4 were significantly more in MPTP-injected old CD-1 mice (MPTP;CD-1 vs C57BL/6J **p<0.01). Type 2 and 3 microglia remained comparable. The C57BL/6J-MPTP showed a significant increase (MPTP;C57BL/6J vs CD-1;***p<0.0008) at middle age

Conclusion: The increase in type-1 microglia in MPTP-treated C57BL/6J at young and middle age suggests recruitment and/or migration of microglia and thus activation of neuroinflammatory cascades. The frank microgliosis in C57BL/6J at middle age hints at higher susceptibility to MPTP, while reduced microgliosis at old age may reflect subthreshold or failed response. The differences in microglial phenotypes with age and in response to MPTP may likely aid the understanding of differential susceptibility to PD

To cite this abstract in AMA style:

S. Choudhury, P. Abhilash, P. Alladi. Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/age-associated-changes-in-microglial-morphology-and-its-role-in-deciphering-susceptibility-to-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/age-associated-changes-in-microglial-morphology-and-its-role-in-deciphering-susceptibility-to-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley